Clinical Trial
doi: 10.1177/00359157760690S222.
Gemfibrozil treatment: a comparison with clofibrate
- PMID: 190609
- PMCID: PMC1864044
- DOI: 10.1177/00359157760690S222
Item in Clipboard
Clinical Trial
Gemfibrozil treatment: a comparison with clofibrate
Proc R Soc Med.
1976.
Abstract
Gemfibrozil was found to be an effective hypotriglyceridaemic agent in types IV, IIb and V hyperlipoproteinaemia. When given at a dose level of 800 mg/day its activity was nearly of the same order of magnitude as 1.5 g/day of clofibrate.
Similar articles
-
A clofibrate controlled trial of gemfibrozil in the treatment of hyperlipidaemias.Proc R Soc Med. 1976;69 Suppl 2(Suppl 2):38-40. doi: 10.1177/00359157760690S209. Proc R Soc Med. 1976. PMID: 798195 Free PMC article. Clinical Trial.
-
Effect of gemfibrozil on lipoprotein concentrations in different types of hyperlipoproteinaemia.Proc R Soc Med. 1976;69 Suppl 2(Suppl 2):28-31. doi: 10.1177/00359157760690S207. Proc R Soc Med. 1976. PMID: 190607 Free PMC article. Clinical Trial.
-
Gemfibrozil and clofibrate in the treatment of hyperlipidaemias. A comparative trial.Proc R Soc Med. 1976;69 Suppl 2(Suppl 2):44-6. doi: 10.1177/00359157760690S211. Proc R Soc Med. 1976. PMID: 798196 Free PMC article. Clinical Trial. No abstract available.
-
Clofibrate and related compounds in hyperlipoproteinaemia. A review.Postgrad Med J. 1975;51(8):suppl 66-71. Postgrad Med J. 1975. PMID: 215983 Review. No abstract available.
-
Does hypolipidemic therapy prevent coronary heart disease?Cardiovasc Clin. 1974;6(2):1-8. Cardiovasc Clin. 1974. PMID: 4374303 Review. No abstract available.
Cited by
-
Gemfibrozil. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in dyslipidaemia.Drugs. 1988 Sep;36(3):314-39. doi: 10.2165/00003495-198836030-00004. Drugs. 1988. PMID: 3056692 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources